Matthew Budd
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Psychiatry and Mental health top 10%
- Psychosomatic Disorders and Their Treatments
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
-
- HIV/AIDS Research and Interventions 4
- Co-authors
- Mary L. Efron (3 shared papers)Kay Tanaka (3 shared papers)K. J. Isselbacher (1 shared paper)David C. McClelland (2 shared papers)Joan Z. Borysenko (1 shared paper)Herbert Benson (1 shared paper)Caroline McLeod (2 shared papers)Lewis B. Holmes (2 shared papers)
- Journals
- New England Journal of Medicine (2 papers)JAMA (1 paper)The Journal of Pediatrics (1 paper)PLANT PHYSIOLOGY (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Matthew Budd
20 papers receiving 705 citations
Peers
Comparison fields: 5 of 112
- Clinical Biochemistry 250
- Psychiatry and Mental health 114
- Infectious Diseases 91
- Family Practice 10
- Clinical Psychology 93
Countries citing papers authored by Matthew Budd
This map shows the geographic impact of Matthew Budd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Budd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Budd more than expected).
Fields of papers citing papers by Matthew Budd
This network shows the impact of papers produced by Matthew Budd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Budd. The network helps show where Matthew Budd may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Budd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1966 | 265 | |
| 2 | 1990 | 126 | |
| 3 | 1967 | 81 | |
| 4 | 1997 | 58 | |
| 5 | 2018 | 50 | |
| 6 | 1964 | 32 | |
| 7 | 2018 | 29 | |
| 8 | 1966 | 22 | |
| 9 | 2011 | 19 | |
| 10 | 2018 | 19 | |
| 11 | 2018 | 18 | |
| 12 | 2018 | 15 | |
| 13 | 2020 | 12 | |
| 14 | 2021 | 10 | |
| 15 | 2023 | 6 | |
| 16 | 1959 | 5 | |
| 17 | 2015 | 1 | |
| 18 | 1999 | 1 | |
| 19 | 1990 | 1 | |
| 20 | 2022 | 1 |
About Matthew Budd
Matthew Budd is a scholar working on Molecular Biology, Infectious Diseases, General Health Professions, Cancer Research and Clinical Psychology, having authored 21 papers that have together received 772 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Metabolism and Genetic Disorders (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Diabetes and associated disorders (2 papers), Immune Cell Function and Interaction (2 papers), Mobile Health and mHealth Applications (2 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Clinical Biochemistry (250 citations), Psychiatry and Mental health (114 citations), Infectious Diseases (91 citations), Family Practice (10 citations) and Clinical Psychology (93 citations). Matthew Budd has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Mary L. Efron, Kay Tanaka, K. J. Isselbacher, David C. McClelland, Joan Z. Borysenko, Herbert Benson, Caroline McLeod, Lewis B. Holmes, John D. Crawford and Kurt J. Isselbacher. Their work appears in journals such as New England Journal of Medicine, JAMA, The Journal of Pediatrics, PLANT PHYSIOLOGY and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.